PCIBo — PCI Biotech Holding ASA Balance Sheet
0.000.00%
Last trade - 00:00
- NOK65.77m
- NOK35.71m
- NOK2.99m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 261 | 188 | 116 | 56.6 | 41.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 14.6 | 13.2 | 12.2 | 6.16 | 2.57 |
Total Other Current Assets | |||||
Total Current Assets | 276 | 201 | 128 | 62.8 | 43.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.28 | 7.99 | 7.66 | 0.723 | 0.297 |
Other Long Term Assets | |||||
Total Assets | 282 | 209 | 136 | 63.5 | 44 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 24.6 | 19.8 | 20.9 | 5.75 | 4.97 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 27.2 | 19.9 | 22.2 | 6.08 | 5.01 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 255 | 189 | 114 | 57.4 | 39 |
Total Liabilities & Shareholders' Equity | 282 | 209 | 136 | 63.5 | 44 |
Total Common Shares Outstanding |